Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.485 AUD | +1.71% | +2.77% | +14.23% |
30/04 | Wilsons Upgrades Monash IVF to Overweight from Market-Weight, Price Target is AU$1.58 | MT |
12/04 | RBC Capital Markets Starts Monash IVF Group at New Sector Perform, Price Target is AU$1.50 | MT |
Valuation
Fiscal Period: Juni | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 328.9 | 206.5 | 331.2 | 366.3 | 446.1 | 578.6 | - | - |
Enterprise Value (EV) 1 | 413.6 | 210.7 | 324.1 | 368.4 | 477.1 | 620.3 | 609.8 | 599.3 |
P/E ratio | - | 11.8 x | - | 20 x | 20.4 x | 21.3 x | 17.7 x | 16.8 x |
Yield | 4.3% | 3.96% | 4.94% | 4.68% | 3.84% | 3.37% | 4% | 4.33% |
Capitalization / Revenue | 2.16 x | 1.42 x | 1.8 x | 1.9 x | 2.09 x | 2.28 x | 2.11 x | 2 x |
EV / Revenue | 2.72 x | 1.45 x | 1.77 x | 1.92 x | 2.23 x | 2.44 x | 2.23 x | 2.07 x |
EV / EBITDA | 10.9 x | 6.06 x | 6.79 x | 7.65 x | 8.93 x | 9.42 x | 8.52 x | 7.89 x |
EV / FCF | - | 8.93 x | - | 22.1 x | - | 20.3 x | 16.2 x | 15.1 x |
FCF Yield | - | 11.2% | - | 4.53% | - | 4.92% | 6.19% | 6.64% |
Price to Book | 1.9 x | 0.54 x | 1.24 x | 1.37 x | 1.63 x | 2.08 x | 2 x | 1.91 x |
Nbr of stocks (in thousands) | 2,35,786 | 3,89,635 | 3,89,635 | 3,89,635 | 3,89,635 | 3,89,635 | - | - |
Reference price 2 | 1.395 | 0.5300 | 0.8500 | 0.9400 | 1.145 | 1.485 | 1.485 | 1.485 |
Announcement Date | 25/08/19 | 23/08/20 | 23/08/21 | 25/08/22 | 21/08/23 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: Juni | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 152 | 145.4 | 183.6 | 192.3 | 213.6 | 254.3 | 274 | 289.7 |
EBITDA 1 | 37.82 | 34.8 | 47.75 | 48.14 | 53.43 | 65.84 | 71.6 | 75.99 |
EBIT 1 | 32.74 | 24.45 | 34.86 | 33.36 | 38.09 | 46.09 | 51.23 | 54.42 |
Operating Margin | 21.54% | 16.81% | 18.99% | 17.35% | 17.83% | 18.13% | 18.7% | 18.78% |
Earnings before Tax (EBT) | 27.48 | 16.13 | - | 26.22 | 29.84 | - | 46.22 | 49.8 |
Net income 1 | 19.85 | 11.73 | 25.15 | 18.41 | 21.84 | 27.31 | 32.28 | 35.14 |
Net margin | 13.06% | 8.06% | 13.7% | 9.57% | 10.22% | 10.74% | 11.78% | 12.13% |
EPS 2 | - | 0.0450 | - | 0.0470 | 0.0560 | 0.0698 | 0.0838 | 0.0882 |
Free Cash Flow 1 | - | 23.6 | - | 16.7 | - | 30.5 | 37.75 | 39.78 |
FCF margin | - | 16.23% | - | 8.68% | - | 12% | 13.78% | 13.73% |
FCF Conversion (EBITDA) | - | 67.82% | - | 34.69% | - | 46.33% | 52.73% | 52.34% |
FCF Conversion (Net income) | - | 201.26% | - | 90.73% | - | 111.66% | 116.93% | 113.19% |
Dividend per Share 2 | 0.0600 | 0.0210 | 0.0420 | 0.0440 | 0.0440 | 0.0501 | 0.0594 | 0.0643 |
Announcement Date | 25/08/19 | 23/08/20 | 23/08/21 | 25/08/22 | 21/08/23 | - | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 77.05 | 68.37 | 90.78 | 92.83 | 101 | 91.32 | 103.3 | 110.3 | 125.7 | 128.3 |
EBITDA 1 | 16.8 | 17.98 | 24.72 | 23.03 | 26.77 | 21.38 | 26.8 | 26.63 | 32.16 | 34.6 |
EBIT 1 | 14.2 | 10.28 | 18.42 | 16.44 | 19.39 | 13.97 | 18.84 | 19.25 | 22.48 | 23.5 |
Operating Margin | 18.43% | 15.03% | 20.29% | 17.71% | 19.2% | 15.3% | 18.24% | 17.45% | 17.88% | 18.32% |
Earnings before Tax (EBT) | 11.05 | - | - | - | 17.13 | 9.091 | 14.76 | 15.08 | 17.74 | - |
Net income 1 | 8.157 | 3.569 | 14.56 | 10.59 | 12.08 | 6.321 | 10.64 | 11.16 | 12.77 | 14.6 |
Net margin | 10.59% | 5.22% | 16.04% | 11.41% | 11.97% | 6.92% | 10.3% | 10.12% | 10.16% | 11.38% |
EPS | 0.0350 | - | - | - | 0.0310 | 0.0160 | 0.0270 | 0.0290 | 0.0330 | - |
Dividend per Share 2 | 0.0210 | - | 0.0210 | 0.0210 | 0.0220 | 0.0220 | 0.0220 | 0.0220 | 0.0250 | 0.0250 |
Announcement Date | 20/02/20 | 23/08/20 | 23/02/21 | 23/08/21 | 16/02/22 | 25/08/22 | 20/02/23 | 21/08/23 | 22/02/24 | - |
Balance Sheet Analysis
Fiscal Period: June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt 1 | 84.7 | 4.2 | - | 2.1 | 31 | 41.7 | 31.2 | 20.7 |
Net Cash position 1 | - | - | 7.1 | - | - | - | - | - |
Leverage (Debt/EBITDA) | 2.24 x | 0.1207 x | - | 0.0436 x | 0.5802 x | 0.6337 x | 0.4363 x | 0.2722 x |
Free Cash Flow 1 | - | 23.6 | - | 16.7 | - | 30.5 | 37.8 | 39.8 |
ROE (net income / shareholders' equity) | 12% | 5.7% | 8.6% | 8.2% | 9.3% | 11.1% | 12.3% | 12.7% |
ROA (Net income/ Total Assets) | 7.2% | 4.1% | 7.18% | 5.03% | 5.44% | 7.23% | 7.65% | 7.82% |
Assets 1 | 275.7 | 286 | 350.1 | 365.6 | 401.4 | 377.6 | 422.1 | 449.6 |
Book Value Per Share 2 | 0.7400 | 0.9800 | 0.6800 | 0.6900 | 0.7000 | 0.7100 | 0.7400 | 0.7800 |
Cash Flow per Share 2 | 0.1400 | 0.1200 | 0.1100 | 0.0800 | 0.1000 | 0.1300 | 0.1300 | 0.1400 |
Capex 1 | 6.54 | 7.5 | 11.3 | 11.8 | 27.8 | 21 | 15.4 | 16.3 |
Capex / Sales | 4.3% | 5.16% | 6.15% | 6.12% | 13.01% | 8.25% | 5.62% | 5.63% |
Announcement Date | 25/08/19 | 23/08/20 | 23/08/21 | 25/08/22 | 21/08/23 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.23% | 383M | |
+13.70% | 80.61B | |
-29.20% | 70.18B | |
+9.72% | 29.08B | |
-11.43% | 16.97B | |
-0.43% | 16.96B | |
-0.31% | 15.26B | |
+3.42% | 12.41B | |
-30.70% | 11.95B | |
-6.75% | 11.93B |
- Stock Market
- Equities
- MVF Stock
- Financials Monash IVF Group Limited